School of Pharmacy Announces Amgen Fellow

Amanda Mathis, a fourth-year PhD student in the Division of Drug Delivery and Disposition, has been selected as the School of Pharmacy ‘s first Amgen Fellow.

Mathis’s research project focuses on intracellular distribution of new drugs being developed to treat international infectious diseases, such as African sleeping sickness, malaria and leishmaniasis. Her adviser is associate professor J.Ed. Hall, PhD.

“I feel honored to be selected as the School’s first Amgen Fellow,” said Mathis. “My research involves investigating a series of diamidine compounds to determine intracellular distribution and how that may impact anti-trypanosomal activity. It is our hope that this research will have an impact on future drug selection and development for African trypanosomiasis, a devastating parasitic disease that has the potential to impact almost 60 million people in sub-Saharan Africa.”

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.